90 related articles for article (PubMed ID: 27264950)
1. A selective splicing variant of hepcidin mRNA in hepatocellular carcinoma cell lines.
Toki Y; Sasaki K; Tanaka H; Yamamoto M; Hatayama M; Ito S; Ikuta K; Shindo M; Hasebe T; Nakajima S; Sawada K; Fujiya M; Torimoto Y; Ohtake T; Kohgo Y
Biochem Biophys Res Commun; 2016 Aug; 476(4):501-507. PubMed ID: 27264950
[TBL] [Abstract][Full Text] [Related]
2. Splicing variant of hepcidin mRNA.
Sasaki K; Kohgo Y; Ohtake T
Vitam Horm; 2019; 110():131-141. PubMed ID: 30798808
[TBL] [Abstract][Full Text] [Related]
3. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
Wang XQ; Luk JM; Leung PP; Wong BW; Stanbridge EJ; Fan ST
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):483-9. PubMed ID: 15701831
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin and DNA promoter methylation in hepatocellular carcinoma.
Udali S; Castagna A; Corbella M; Ruzzenente A; Moruzzi S; Mazzi F; Campagnaro T; De Santis D; Franceschi A; Pattini P; Gottardo R; Olivieri O; Perbellini L; Guglielmi A; Choi SW; Girelli D; Friso S
Eur J Clin Invest; 2018 Feb; 48(2):e12870. PubMed ID: 29235098
[TBL] [Abstract][Full Text] [Related]
5. Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression.
Lu X; Feng X; Man X; Yang G; Tang L; Du D; Zhang F; Yuan H; Huang Q; Zhang Z; Liu Y; Strand D; Chen Z
Clin Cancer Res; 2009 May; 15(10):3287-96. PubMed ID: 19447873
[TBL] [Abstract][Full Text] [Related]
6. [Molecular cloning and alternative splicing analysis of hepatoma associated gene HTA].
Liu Y; Zhao Y; Fang S; Li Y; Li G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 38(9):869-75. PubMed ID: 24071698
[TBL] [Abstract][Full Text] [Related]
7. Activated macrophages induce hepcidin expression in HuH7 hepatoma cells.
Matak P; Chaston TB; Chung B; Srai SK; McKie AT; Sharp PA
Haematologica; 2009 Jun; 94(6):773-80. PubMed ID: 19454498
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of iron regulatory hormone hepcidin by interferon α.
Ichiki K; Ikuta K; Addo L; Tanaka H; Sasaki Y; Shimonaka Y; Sasaki K; Ito S; Shindo M; Ohtake T; Fujiya M; Torimoto Y; Kohgo Y
J Gastroenterol Hepatol; 2014 Feb; 29(2):387-94. PubMed ID: 23926964
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression.
Morita Y; Sakaguchi T; Ikegami K; Goto-Inoue N; Hayasaka T; Hang VT; Tanaka H; Harada T; Shibasaki Y; Suzuki A; Fukumoto K; Inaba K; Murakami M; Setou M; Konno H
J Hepatol; 2013 Aug; 59(2):292-9. PubMed ID: 23567080
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin in hepatocellular carcinoma.
Joachim JH; Mehta KJ
Br J Cancer; 2022 Jul; 127(2):185-192. PubMed ID: 35264787
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning and mRNA expression of a hepcidin gene from the spinyhead croaker, Collichthys lucidus.
Sang C; Lin Y; Jiang K; Zhang F; Song W
Genet Mol Res; 2015 Dec; 14(4):16050-9. PubMed ID: 26662398
[TBL] [Abstract][Full Text] [Related]
12. Expression of wild-type and variant estrogen receptor alpha in liver carcinogenesis and tumor progression.
Miceli V; Cocciadiferro L; Fregapane M; Zarcone M; Montalto G; Polito LM; Agostara B; Granata OM; Carruba G
OMICS; 2011 May; 15(5):313-7. PubMed ID: 21348637
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation of hepatic iron sensing genes and the regulation of hepcidin expression.
Sharp PA; Clarkson R; Hussain A; Weeks RJ; Morison IM
PLoS One; 2018; 13(5):e0197863. PubMed ID: 29771984
[TBL] [Abstract][Full Text] [Related]
14. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
15. Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters.
Kanda M; Nomoto S; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
J Surg Oncol; 2008 Sep; 98(3):190-6. PubMed ID: 18537151
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel human tissue factor splice variant that is upregulated in tumor cells.
Chand HS; Ness SA; Kisiel W
Int J Cancer; 2006 Apr; 118(7):1713-20. PubMed ID: 16217771
[TBL] [Abstract][Full Text] [Related]
17. Rbfox2 mediates exon 11 inclusion in insulin receptor pre-mRNA splicing in hepatoma cells.
Nakura T; Ozoe A; Narita Y; Matsuo M; Hakuno F; Kataoka N; Takahashi SI
Biochimie; 2021 Aug; 187():25-32. PubMed ID: 34022289
[TBL] [Abstract][Full Text] [Related]
18. E167K polymorphism of TM6SF2 gene affects cell cycle of hepatocellular carcinoma cell HEPA 1-6.
Du S; Lu L; Miao Y; Jin W; Li C; Xin Y; Xuan S
Lipids Health Dis; 2017 Apr; 16(1):76. PubMed ID: 28407767
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma.
Niwa Y; Matsumura M; Shiratori Y; Imamura M; Kato N; Shiina S; Okudaira T; Ikeda Y; Inoue T; Omata M
Hepatology; 1996 Jun; 23(6):1384-92. PubMed ID: 8675155
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines.
Fujii C; Nakamoto Y; Lu P; Tsuneyama K; Popivanova BK; Kaneko S; Mukaida N
Int J Cancer; 2005 Mar; 114(2):209-18. PubMed ID: 15540201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
